KSHV‐associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|137|2|251-261

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.2, 2015-07, pp. : 251-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful Treatment of Autoimmune Hemolytic Anemia Associated with Multicentric Castleman Disease by Anti-Interleukin-6 Receptor Antibody (Tocilizumab) Therapy

By  

Acta Haematologica, Vol. 126, Iss. 3, 2011-07 ,pp. : 147-150

Karger

Access to resources Recommend Favorite

Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers

By Fujimuro Masahiro   Hayward S.  

Journal of Molecular Medicine, Vol. 82, Iss. 4, 2004-04 ,pp. : 223-231

Springer Publishing Company

Access to resources Recommend Favorite

Plasmablastic microlymphoma arising in human herpesvirus‐8‐associated multicentric Castleman disease in a human immunodeficiency virus‐seronegative patient with clinical response to anti‐interleukin‐6 therapy

By  

HISTOPATHOLOGY, Vol. 67, Iss. 6, 2015-12 ,pp. : 930-932

John Wiley & Sons Inc

Access to resources Recommend Favorite

AIDS, Multicentric Castleman's Disease, and Plasmablastic Leukemia: Report of a Long-Term Survival

By Horster S.  

Infection, Vol. 32, Iss. 5, 2004-10 ,pp. : 296-298

Springer Publishing Company

Access to resources Recommend Favorite

Sustained remission of severe multicentric castleman disease following multiagent chemotherapy and tocilizumab maintenance

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 4, 2014-04 ,pp. : 737-739

John Wiley & Sons Inc

Access to resources Recommend Favorite